Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esbatech AgfiledCriticalEsbatech Ag
Priority to MYPI2017000799ApriorityCriticalpatent/MY176238A/en
Publication of MY176238ApublicationCriticalpatent/MY176238A/en
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
The present invention relates to particularly stable and soluble scFv antibodies and Fab fragments specific for TNFa, which comprise specific light chain and heavy chain sequences that are optimized for stability , solubility, in vitro and in vivo binding of TNFa, and low immunogenicity. Said antibodies are designed for the diagnosis and/or treatment of TNFa, related disorders. The nucleic acids , vectors and host cells for expression of the recombinant antibodies of the invention, methods for isolating them and the use of said antibodies in medicine are also disclosed.
MYPI2017000799A2007-11-292007-11-29Stable and soluble antibodies inhibiting tnf()
MY176238A
(en)
Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers
Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers